Mega Genomics Sets RMB0.15 Final Dividend for FY2025; Payment Slated for 9 July 2026

Bulletin Express

04/28

Hong Kong—Mega Genomics Limited has confirmed a final ordinary dividend of RMB 0.15 per share for the financial year ended 31 December 2025, according to an updated filing released on 29 April 2026. The update specifies the dividend payment date, now fixed for 9 July 2026.

Shareholders will vote on the distribution at the annual general meeting scheduled for 21 May 2026. Key timetable details are as follows:

• Ex-dividend date: 26 May 2026 • Last day to lodge share transfers: 27 May 2026 (16:30) • Book-closure period: 28 – 29 May 2026 • Record date: 29 May 2026 • Payment date: 9 July 2026

The dividend will be paid in Hong Kong dollars; the exact HKD amount and applicable exchange rate will be announced closer to the payment date. Tricor Investor Services Limited will act as the share registrar.

The announcement contains no provisions for withholding tax or related warrant and convertible-security matters. Mega Genomics’ board currently comprises three executive directors, one non-executive director, and three independent non-executive directors.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1183970961"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1183970961\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1183970961?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-28 21:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1183970961","market":"us","top_or_hot":-1,"title":"Mega Genomics Sets RMB0.15 Final Dividend for FY2025; Payment Slated for 9 July 2026","media":"Bulletin Express","content":"<p>Hong Kong—Mega Genomics Limited has confirmed a final ordinary dividend of RMB 0.15 per share for the financial year ended 31 December 2025, according to an updated filing released on 29 April 2026. The update specifies the dividend payment date, now fixed for 9 July 2026.</p>\n<p>Shareholders will vote on the distribution at the annual general meeting scheduled for 21 May 2026. Key timetable details are as follows:</p>\n<p>• Ex-dividend date: 26 May 2026  \n• Last day to lodge share transfers: 27 May 2026 (16:30)  \n• Book-closure period: 28 – 29 May 2026  \n• Record date: 29 May 2026  \n• Payment date: 9 July 2026</p>\n<p>The dividend will be paid in Hong Kong dollars; the exact HKD amount and applicable exchange rate will be announced closer to the payment date. Tricor Investor Services Limited will act as the share registrar.</p>\n<p>The announcement contains no provisions for withholding tax or related warrant and convertible-security matters. Mega Genomics’ board currently comprises three executive directors, one non-executive director, and three independent non-executive directors.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Mega Genomics Sets RMB0.15 Final Dividend for FY2025; Payment Slated for 9 July 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMega Genomics Sets RMB0.15 Final Dividend for FY2025; Payment Slated for 9 July 2026\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-04-28 21:23</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Hong Kong—Mega Genomics Limited has confirmed a final ordinary dividend of RMB 0.15 per share for the financial year ended 31 December 2025, according to an updated filing released on 29 April 2026. The update specifies the dividend payment date, now fixed for 9 July 2026.</p>\n<p>Shareholders will vote on the distribution at the annual general meeting scheduled for 21 May 2026. Key timetable details are as follows:</p>\n<p>• Ex-dividend date: 26 May 2026  \n• Last day to lodge share transfers: 27 May 2026 (16:30)  \n• Book-closure period: 28 – 29 May 2026  \n• Record date: 29 May 2026  \n• Payment date: 9 July 2026</p>\n<p>The dividend will be paid in Hong Kong dollars; the exact HKD amount and applicable exchange rate will be announced closer to the payment date. Tricor Investor Services Limited will act as the share registrar.</p>\n<p>The announcement contains no provisions for withholding tax or related warrant and convertible-security matters. Mega Genomics’ board currently comprises three executive directors, one non-executive director, and three independent non-executive directors.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06667","symbol_name":"美因基因","start_time":0,"source_url":"","article_id":"1183970961","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1183970961","pubTimestamp":1777382626,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hong Kong—Mega Genomics Limited has confirmed a final ordinary dividend of RMB 0.15 per share for the financial year ended 31 December 2025, according to an updated filing released on 29 April 2026....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06667":"美因基因"},"translate_title":"兆丰基因设定2025财年末期股息人民币0.15元；预计于2026年7月9日付款","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06667":1},"content_text":"Hong Kong—Mega Genomics Limited has confirmed a final ordinary dividend of RMB 0.15 per share for the financial year ended 31 December 2025, according to an updated filing released on 29 April 2026. The update specifies the dividend payment date, now fixed for 9 July 2026.\nShareholders will vote on the distribution at the annual general meeting scheduled for 21 May 2026. Key timetable details are as follows:\n• Ex-dividend date: 26 May 2026  \n• Last day to lodge share transfers: 27 May 2026 (16:30)  \n• Book-closure period: 28 – 29 May 2026  \n• Record date: 29 May 2026  \n• Payment date: 9 July 2026\nThe dividend will be paid in Hong Kong dollars; the exact HKD amount and applicable exchange rate will be announced closer to the payment date. Tricor Investor Services Limited will act as the share registrar.\nThe announcement contains no provisions for withholding tax or related warrant and convertible-security matters. Mega Genomics’ board currently comprises three executive directors, one non-executive director, and three independent non-executive directors.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}